This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Universitetet I Oslo. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations by Fredrik Hellem Schjesvold
Introduction
Fredrik Hellem Schjesvold is a notable inventor based in Jar, Norway. He has made significant contributions to the field of cancer treatment through his innovative research and patents. His work focuses on developing therapies for ALK-negative cancers, which are often challenging to treat.
Latest Patents
Fredrik holds 1 patent for his invention titled "ALK inhibitors for treatment of ALK-negative cancer and plasma cell-mediated diseases." This patent describes a method of treating ALK-negative/LTK-positive cancer by administering a pharmaceutically effective dose of a linear inhibitor of ALK. The invention is particularly useful in treating multiple myeloma, including cases that are resistant to proteasome inhibitors.
Career Highlights
Fredrik is affiliated with the University of Oslo, where he conducts his research and develops his innovative treatments. His work has garnered attention in the medical community for its potential to improve outcomes for patients with difficult-to-treat cancers.
Collaborations
Fredrik has collaborated with notable colleagues, including Hesso Farhan and Ludvig Munthe, to advance his research and explore new therapeutic avenues.
Conclusion
Fredrik Hellem Schjesvold's contributions to cancer treatment through his innovative patents highlight the importance of research in developing effective therapies. His work continues to inspire advancements in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile